Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 2 Systemic abnormalities in AD

Published byΚαλυψώ Ρέντης Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 2 Systemic abnormalities in AD"— Presentation transcript:

1 Figure 2 Systemic abnormalities in AD
Figure 2 | Systemic abnormalities in AD. Various systemic abnormalities have been found in patients with Alzheimer disease (AD). Red boxes highlight AD risk variants in genes related to innate immunity, phagocytosis of amyoid-β (Aβ) by immune cells, and lipid metabolism in periphery and brain, respectively, which were identified in genome-wide association studies and candidate-gene studies of sporadic AD. APP, amyloid precursor protein; BA, basilar artery; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; HDL-C, HDL-cholesterol; IGF, insulin-like growth factor; LDL-C, LDL-cholesterol; LPS, lipopolysaccharide; LTICA, left terminal internal carotid artery; OSA, obstructive sleep apnoea; PI, pulsatility index; RBC, red blood cells; RI, resistance index; RTICA, right terminal internal carotid artery; TNF, tumour necrosis factor. Wang, J. et al. (2017) A systemic view of Alzheimer disease — insights from amyloid‑β metabolism beyond the brain Nat. Rev. Neurol. doi: /nrneurol

Download ppt "Figure 2 Systemic abnormalities in AD"

Similar presentations

Genetic Variants Associated with Late-Onset Alzheimer Disease By: Sarah Hinton, University of Georgia 2014 Pharm.D. candidate Preceptor: Dr. Ali Rahimi.

Genetic Variants Associated with Late-Onset Alzheimer Disease By: Sarah Hinton, University of Georgia 2014 Pharm.D. candidate Preceptor: Dr. Ali Rahimi.
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.
Time frame : Baseline to post intervention

Time frame : Baseline to post intervention
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Life expectancy at birth in all countries included

Figure 3 Life expectancy at birth in all countries included
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 The US Centers for Disease Control and

Figure 2 The US Centers for Disease Control and
Figure 5 Inter-relationships between sleep apnoea, CKD and brain injury Figure 5 | Inter-relationships between sleep apnoea, CKD and brain injury. In chronic.

Figure 5 Inter-relationships between sleep apnoea, CKD and brain injury Figure 5 | Inter-relationships between sleep apnoea, CKD and brain injury. In chronic.
Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET
Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.

Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.
Figure 2 Proinflammatory mechanisms in CKD

Figure 2 Proinflammatory mechanisms in CKD
Figure 2 Systemic immune responses to cryptococcal antigen

Figure 2 Systemic immune responses to cryptococcal antigen
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Proportion of patients for whom NEDA

Figure 3 Proportion of patients for whom NEDA
Figure 5 Number of AHSCT procedures for

Figure 5 Number of AHSCT procedures for
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Physiological metabolism of Aβ in the brain and periphery

Figure 1 Physiological metabolism of Aβ in the brain and periphery
Figure 2 Co-stimulatory receptors as immunomodulatory targets

Figure 2 Co-stimulatory receptors as immunomodulatory targets

Similar presentations

Ads by Google